Source: Annual Congress 2009 - COPD: basic science and clinical studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Dimakou, E. Neofytou, S. Schiza, N. Tzanakis, A. Gussiou, N. Siafakas, E. Tzortzaki (Heraklion, Greece). Differences between COPD and bronchiectasis at the microsatellite DNA level. Eur Respir J 2009; 34: Suppl. 53, 920

Member's Comments

No comment yet.

Related content which might interest you: Differential diagnosis of COPD and asthma at the microsatellite DNA level Source: Eur Respir J 2004; 24: Suppl. 48, 694s Year: 2004 DNA microsatellite instability is associated with exacerbations in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005 Microsatellite DNA instability and COPD exacerbations Source: Eur Respir J 2008; 32: 612-618 Year: 2008 Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: 472-478 Year: 2006 Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap Source: Eur Respir J 2014; 43: 421-429 Year: 2013 Polymorphic variation in surfactant protein B is associated with COPD exacerbations Source: Eur Respir J 2008; 32: 938-944 Year: 2008 Changes in DNA methylation after corticosteroids treatment in COPD patients Source: Virtual Congress 2020 – Cutting edge science: novel molecules and mechanisms of airway diseases Year: 2020 Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap Source: Annual Congress 2013 –Is it really asthma? Year: 2013 A genome wide DNA microsatellite association study of Japanese patients with high altitude pulmonary edema Source: Annual Congress 2011 - Clinical features of human pulmonary hypertension Year: 2011 The median number of COPD exacerbations per year in patients with different polymorphisms of the gene ADRB2 Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 COPD and asthma overlap with bronchiectasis Source: Eur Respir Monogr 2018; 81: 167-185 Year: 2018 Gender differences in dyspnea and its association with lung function in COPD and asthma Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017 Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients Source: Eur Respir J 2008; 32: 372-378 Year: 2008 COPD assessment test correlation with the increase of the inflammatory markers in COPD exacerbations Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 LSC - 2020 - The lung DNA methylation profile of patients with COPD: relationship with smoking and airflow limitation severity. Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 The clinical significance and frequency of bronchiectasis in COPD patients Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Relationship between COPD characteristics and airway bacterial load measured using 16S qPCR Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015